单次行为医学课程对服用处方阿片类药物的慢性疼痛患者的疗效与机制:随机对照试验研究方案
本研究为随机双盲临床试验,旨在检验2小时单次技能型疼痛管理课程相较于2小时健康教育主动对照组,在服用阿片类药物的慢性疼痛成人患者中的优效性。计划纳入136例混合病因慢性疼痛患者,按1:1随机分组,评估疼痛控制、疼痛特异性痛苦自我调节及以每日吗啡当量衡量的阿片使用减少,随访至治疗后12个月。
要点
- 单次2小时技能型疼痛管理课程可能改善疼痛控制与自我调节。
- 主要目标包括减少阿片类药物使用(每日吗啡当量)。
- 随机双盲设计,随访长达12个月。
核心结论
- 该试验旨在验证单次技能型疼痛管理课程相较于健康教育在疼痛控制、疼痛特异性痛苦自我调节及减少阿片使用方面的优效性。
研究设计与样本
- 随机双盲临床试验,纳入136例服用阿片类药物的混合病因慢性疼痛成人患者,1:1随机分配至2小时技能型疼痛管理课程组或2小时健康教育主动对照组。
- 结果评估者设盲,随访至治疗后12个月。
关键数值与推荐
- 主要结局包括疼痛控制、疼痛特异性痛苦的自我调节及以每日吗啡当量衡量的阿片使用减少。
- 研究假设技能型疼痛课程在上述结局上优于健康教育组。
临床怎么用
- 若验证有效,单次2小时技能型疼痛管理课程可作为可扩展、经济的干预,减少阿片需求并预防滥用。
- 阐明阿片使用机制有助于优化未来靶向治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Independent of pain intensity, pain-specific distress is highly predictive of pain treatment needs, including the need for prescription opioids. Given the inherently distressing nature of chronic pain, there is a need to equip individuals with pain education and self-regulatory skills that are shown to improve adaptation and improve their response to medical treatments. Brief, targeted behavioral medicine interventions may efficiently address the key individual factors, improve self-regulation in the context of pain, and reduce the need for opioid therapy. This highlights the critical need for targeted, cost-effective interventions that efficiently address the key psychological factors that can amplify the need for opioids and increased risk for misuse. In this trial, the primary goal is to test the comparative efficacy of a single-session skills-based pain management class to a health education active control group among patients with chronic pain who are taking opioids. METHODS/DESIGN: Our study is a randomized, double-blind clinical trial testing the superiority of our 2-h, single-session skills-based pain management class against a 2-h health education class. We will enroll 136 adult patients with mixed-etiology chronic pain who are taking opioid prescription medication and randomize 1:1 to one of the two treatment arms. We hypothesize superiority for the skills-based pain class for pain control, self-regulation of pain-specific distress, and reduced opioid use measured by daily morphine equivalent. Team researchers masked to treatment assignment will assess outcomes up to 12 months post treatment. DISCUSSION: This study aims to test the utility of a single-session, 2-h skills-based pain management class to improve self-regulation of pain and reduce opioid use. Findings from our project have the potential to shift current research and clinical paradigms by testing a brief and scalable intervention that could reduce the need for opioids and prevent misuse effectively, efficiently, and economically. Further, elucidation of the mechanisms of opioid use can facilitate refinement of more targeted future treatments. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03950791. Registered on 10 May 2019.
引用
- Ziadni MS, Chen AL, Winslow T, et al. Efficacy and mechanisms of a single-session behavioral medicine class among patients with chronic pain taking prescription opioids: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32532346. doi:10.1186/s13063-020-04415-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。